Enalapril Maleate Oral Solution

• Hyperkalemia: Enalapril can cause the body to retain potassium. While often asymptomatic, severely high potassium levels can lead to dangerous heart rhythm disturbances.
• Proteinuria: The presence of excess protein in the urine, which may indicate changes in kidney function.
• Neutropenia/Agranulocytosis: A rare but serious decrease in white blood cells, which can make the body more susceptible to infections.
• Liver Enzyme Elevation: Rare cases of hepatitis or cholestatic jaundice have been reported.

> Warning: Stop taking Enalapril and call your doctor immediately if you experience any of the following serious symptoms.

1. 1Angioedema: This is a life-threatening allergic reaction characterized by swelling of the face, lips, tongue, and throat. It can block the airway and make breathing impossible. This risk is significantly higher in Black patients compared to other ethnic groups.
2. 2Kidney Failure: Symptoms include a significant decrease in urine output, swelling in the ankles or feet, and shortness of breath.
3. 3Liver Toxicity: Look for yellowing of the skin or eyes (jaundice), dark urine, and severe upper stomach pain.
4. 4Anaphylaxis: Severe allergic reactions including hives, difficulty breathing, and a rapid or weak pulse.
5. 5Chest Pain (Angina): While Enalapril is used for heart conditions, some patients may experience new or worsening chest pain during the start of therapy.

Prolonged use of Enalapril requires ongoing monitoring of renal function and electrolyte balance. Long-term use is generally safe, but some patients may develop a slow decline in kidney function over many years, especially if they have underlying renal artery stenosis (narrowing of the arteries to the kidneys).

Fetal Toxicity: Enalapril carries a strict FDA Black Box Warning regarding its use during pregnancy. When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. Potential complications include skull hypoplasia (underdevelopment), anuria (lack of urine production), renal failure, and limb contractures. If pregnancy is detected, Enalapril must be discontinued as soon as possible. Discuss alternative blood pressure treatments with your doctor if you are planning to become pregnant.

Report any unusual symptoms to your healthcare provider immediately. Early detection of side effects can prevent serious complications.

Your healthcare provider will require regular lab tests to ensure the medication is working safely:

1. 1Serum Creatinine and BUN: To monitor kidney function.
2. 2Serum Potassium: To check for hyperkalemia (high potassium levels).
3. 3Blood Pressure Monitoring: Regular checks at home and in the clinic to ensure the dose is effective.
4. 4White Blood Cell Count: Occasionally monitored in patients with collagen vascular diseases (like Lupus) to check for neutropenia.

Because Enalapril can cause dizziness, especially during the first few days of treatment, you should avoid driving or operating heavy machinery until you know how the medication affects you. Fainting (syncope) can occur unexpectedly.

Alcohol can further lower your blood pressure, increasing the risk of dizziness, fainting, and falls. It is generally advised to limit or avoid alcohol consumption while taking Enalapril.

Do not stop taking Enalapril suddenly. While it does not typically cause a "withdrawal syndrome," your blood pressure may rise rapidly, increasing the risk of a stroke or heart attack. If you need to stop the medication, your doctor will provide a tapering schedule.

> Important: Discuss all your medical conditions, especially kidney disease, liver disease, or a history of allergic reactions, with your healthcare provider before starting Enalapril.

• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Medications like ibuprofen (Advil/Motrin), naproxen (Aleve), and celecoxib can reduce the blood-pressure-lowering effect of Enalapril. Furthermore, in patients who are elderly or have poor kidney function, the combination can lead to acute kidney failure.
• Diuretics (Water Pills): While often used together, the initial combination can cause a sharp drop in blood pressure. Your doctor may adjust your diuretic dose before starting Enalapril.
• Gold Therapy: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy.

• High-Potassium Foods: While a healthy diet is encouraged, excessive consumption of high-potassium foods (like bananas, oranges, and leafy greens) should be discussed with your doctor to avoid hyperkalemia.
• Salt Substitutes: Many salt substitutes contain potassium chloride instead of sodium chloride. These should be avoided unless approved by your healthcare provider.

• Natural Licorice: Can cause sodium retention and potassium loss, counteracting the effects of Enalapril.
• St. John's Wort: May theoretically alter the metabolism of various cardiovascular drugs, though specific data for Enalapril is limited.
• Garlic/Ginger: May have mild blood-pressure-lowering effects, which could potentially increase the risk of hypotension when combined with Enalapril.

Enalapril may cause a false-positive result in certain urine tests for acetone. It may also slightly increase serum bilirubin and liver enzymes, which could be misinterpreted during routine blood work.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list helps prevent dangerous interactions.

Healthcare providers will perform a careful risk-benefit analysis in the following cases:

• Renal Artery Stenosis: In patients with bilateral renal artery stenosis (narrowing of both arteries supplying the kidneys), Enalapril can cause a rapid decline in kidney function and acute renal failure.
• Aortic Stenosis: Patients with severe narrowing of the heart's aortic valve may be at risk for coronary hypoperfusion (low blood flow to the heart muscle) if their blood pressure drops too low.
• Hyperkalemia: Patients who already have high potassium levels should not start Enalapril until the electrolyte imbalance is corrected.
• Volume Depletion: Patients who are severely dehydrated or have very low sodium levels should be stabilized before starting Enalapril to prevent circulatory collapse.

There is a high degree of cross-sensitivity among ACE inhibitors. If you have had a severe allergic reaction to one drug in this class, you are highly likely to react to Enalapril. However, there is generally no cross-sensitivity between ACE inhibitors and other classes of blood pressure medications like Beta-blockers or Calcium Channel Blockers.

> Important: Your healthcare provider will evaluate your complete medical history, including any previous allergic reactions to medications, before prescribing Enalapril.

Enalapril is approved for hypertension in children older than one month. It has been shown to be effective and generally well-tolerated in this population. However, it is not recommended for children with very poor kidney function (GFR <30 mL/min). Long-term effects on growth and development have not been specifically studied, but the drug has been used safely in pediatrics for decades.

Clinical studies did not identify overall differences in safety or effectiveness between elderly (65 and older) and younger patients. However, because older adults are more likely to have decreased renal function and take multiple medications (polypharmacy), they should be started on lower doses. There is an increased risk of falls in the elderly if Enalapril causes significant orthostatic hypotension (dizziness upon standing).

Patients with kidney disease require careful dose titration. Enalaprilat is removed by hemodialysis; on dialysis days, the dose should be administered after the procedure to ensure the drug remains in the system to control blood pressure. For those with a creatinine clearance less than 30 mL/min, the initial dose is reduced by 50%.

In patients with cirrhosis, the conversion of Enalapril to enalaprilat may be slowed, but the ultimate therapeutic effect is usually maintained. No specific starting dose adjustment is required for mild-to-moderate liver disease, but close monitoring for side effects is recommended.

> Important: Special populations require individualized medical assessment and frequent monitoring by a healthcare professional.

| Parameter | Value |

|---|---|

| Bioavailability | ~60% (as Enalapril) |

| Protein Binding | 50% to 60% (as Enalaprilat) |

| Half-life | ~11 hours (effective for accumulation) |

| Tmax | 1 hour (Enalapril); 4 hours (Enalaprilat) |

| Metabolism | Hepatic de-esterification to Enalaprilat |

| Excretion | Renal 94%, Fecal 6% |

• Molecular Formula: C20H28N2O5 • C4H4O4
• Molecular Weight: 492.52 g/mol
• Solubility: Sparingly soluble in water; soluble in ethanol; freely soluble in methanol.
• Structure: It is a derivative of two amino acids, L-alanine and L-proline.

Enalapril is a member of the ACE inhibitor class. It is chemically related to drugs like Lisinopril and Ramipril. Unlike Lisinopril, which is active as administered, Enalapril requires liver metabolism to become active, classifying it as a prodrug. It is distinct from Thiazide diuretics, though it is frequently prescribed alongside them to achieve synergistic blood pressure control.